September 24, 2023 9:15 AM
Latest:
  • Canada’s Grocery Costs and The Trudeau Tax “Solution”
  • Robinhood Sees Operating Metrics Continue To Deteriorate
  • European Natural Gas Prices Jump 10% This Week, Reaching One-Month High
  • Curaleaf’s Alabama Cannabis License Application May Have Used A Dead Applicant
  • Should Alberta Leave The Canada Pension Plan To Save $5 Billion?
The Deep Dive

the deep dive

Providing stock analysis for investors of the Canadian junior markets

  • Home
  • Latest
    • Automotive
    • Latest
    • Cannabis
    • Commentary
    • Education
    • Full Analysis
    • Gold
    • Industrials
    • Macro
    • Oil
    • Psychedelics
    • Resources
    • Technology
  • Cannabis
  • Technology
  • Company Profiles
    • Hemlo Explorers
    • HydroGraph Clean Power
    • Power Nickel
    • Sonoran Desert Copper
    • Riverside Resources
    • Slave Lake Zinc
    • Trillion Energy
    • Verses AI
    • Vortex Metals
  • Resources
  • About
  • Contact Us
  • Advertise With Us

Bright Minds Biosciences

Latest News Psychedelics 

Bright Minds Begins Phase 1 Clinical Trials Focused On Treating Dravet Syndrome

August 31, 2022 8:52 AMAugust 31, 2022 8:52 AM Jay Lutz 0 Comments Bright Minds Biosciences

Phase 1 trials are officially underway for Bright Minds Biosciences (CSE: DRUG) and their lead product, referred to as BMB-101.

Share
Tweet
Share
Read more
Biotech Latest News 

Bright Minds Biosciences Looks To Raise $4.0 Million Via Overnight Offering

August 24, 2022 8:40 AMAugust 24, 2022 8:40 AM Jay Lutz 0 Comments Bright Minds Biosciences

After several days of intense volatility, Bright Minds Biosciences (CSE: DRUG) is looking to capitalize on the sudden investor interest.

Share
Tweet
Share
Read more
Latest News Psychedelics 

Bright Minds Moves Into Clinical Development Stage Following Positive Toxicity Results

March 14, 2022 7:54 AMMarch 14, 2022 7:54 AM Jay Lutz 0 Comments Bright Minds Biosciences

Drug development continues for the Bright Minds Biosciences (CSE: DRUG) lead product. The firm this morning published positive results from

Share
Tweet
Share
Read more
Full Analysis Latest Psychedelics Video Series 

Bright Minds Bioscience: A Deep Dive

December 2, 2021 1:30 PMDecember 3, 2021 8:16 AM Jay Lutz 0 Comments Bright Minds Biosciences

Today we are diving into a firm focused on mental health, whom is also a recently Nasdaq-listed Psychedelic Stock, Bright

Share
Tweet
Share
Read more
Latest News Psychedelics 

Bright Minds Bioscience Approved For Nasdaq Listing

November 3, 2021 8:50 AMNovember 3, 2021 8:50 AM Jay Lutz 1 Comment Bright Minds Biosciences

There’s another Canadian firm set to trade on the Nasdaq market. Bright Minds Bioscience (CSE: DRUG) this morning announced that

Share
Tweet
Share
Read more
Latest News Psychedelics 

Bright Minds Biosciences Advances Lead Serotonergic Drug Candidate To Toxicology Studies, Targets Human Trials In 2022

September 22, 2021 3:24 PMSeptember 22, 2021 2:48 PM ER Velasco 0 Comments Bright Minds Biosciences

Bright Minds Biosciences (CSE: DRUG) shared today scientific updates regarding its serotonergic drug pipeline. This includes the announcement of advancing

Share
Tweet
Share
Read more
Latest News Psychedelics 

Bright Minds: Eight Capital Assigns $11.50 Price Target To Firm

September 20, 2021 10:09 AMSeptember 19, 2021 10:08 PM Justin Young 0 Comments Analyst Estimate, Bright Minds Biosciences

Last week, Eight Capital launched coverage on a basket of psychedelic companies. This comes after they produced an industry primer

Share
Tweet
Share
Read more
Latest Psychedelics Video Series 

Explainer: Anti Alzheimer’s, Dravet Syndrome, Epilepsy & Addiction Drugs – The Daily Dive

September 10, 2021 1:30 PMSeptember 10, 2021 1:15 PM Jay Lutz 0 Comments Bright Minds Biosciences, Ian McDonald, The Daily Dive

On today’s Daily Dive, Cassandra welcomes back Ian McDonald, CEO of Bright Minds Biosciences (CSE: DRUG). He shares the promising

Share
Tweet
Share
Read more
Latest News Psychedelics 

Bright Minds Biosciences Proprietary Compound Shows Reduction Of Seizures In Pre-Clinical Studies

August 18, 2021 8:54 AMAugust 18, 2021 8:54 AM Jay Lutz 0 Comments Bright Minds Biosciences

Bright Minds Biosciences (CSE: DRUG) this morning announced preliminary results from an ongoing study being conducted by the firm. The

Share
Tweet
Share
Read more
Latest Psychedelics Video Series 

Bright Minds: Focusing On Second Generation Psychedelic Compounds – The Daily Dive

June 21, 2021 1:30 PMJune 21, 2021 11:57 AM Jay Lutz 0 Comments Bright Minds Biosciences, Gideon Shapiro, The Daily Dive

Starting off this week on the Daily Dive is that of Dr Gideon Shapiro, whom is VP of Discovery at

Share
Tweet
Share
Read more
  • ← Previous

Latest

  • Canada’s Grocery Costs and The Trudeau Tax “Solution”

  • Robinhood Sees Operating Metrics Continue To Deteriorate

  • European Natural Gas Prices Jump 10% This Week, Reaching One-Month High

  • Curaleaf’s Alabama Cannabis License Application May Have Used A Dead Applicant

  • Should Alberta Leave The Canada Pension Plan To Save $5 Billion?

  • Could Apple Buy ESPN From Disney?

  • The Crime In Barrick Gold That Costs Millions Annually

  • Chinese Interference: RCMP Probe Death of a Chinese Dissident in BC

Video

Lithium Chile: US$1.8 Billion Pre-Tax NPV(8%) At Arizaro – With Michelle DeCecco
Latest Lithium Resources Video Series 

Lithium Chile: US$1.8 Billion Pre-Tax NPV(8%) At Arizaro – With Michelle DeCecco

August 29, 2023 1:30 PM Jay Lutz 0

Michelle DeCecco, Vice President and COO of Lithium Chile (TSXV: LITH) joins us today to discuss the Arizaro lithium project in Argentina.

Trending

  • Tecpetrol Raises Alpha Lithium Takeover Bid to $1.48 Per Share
  • The Crime In Barrick Gold That Costs Millions Annually
  • BioSteel Owes Millions To NHL, Professional Sports Teams: Bankruptcy Filing
  • European Natural Gas Prices Jump 10% This Week, Reaching One-Month High
  • Could Apple Buy ESPN From Disney?

News

First Phosphate Enters MOU For Production Of Up To 40,000 Tonnes of LFP Cathode Active Material
Latest News Resources 

First Phosphate Enters MOU For Production Of Up To 40,000 Tonnes of LFP Cathode Active Material

September 14, 2023 8:50 AM Jay Lutz 0

First Phosphate (CSE: PHOS) mid-day yesterday revealed that it has entered into a memorandum of understanding to support the production of lithium iron phosphate cathode active material.

DiagnaMed Expects Brain Health AI Platform To Be Commercialized In Q4 2023
Biotech Latest News 

DiagnaMed Expects Brain Health AI Platform To Be Commercialized In Q4 2023

September 13, 2023 9:58 AM Jay Lutz 0
West Red Lake Gold Hits 70.80 g/t Gold Over 8.3 Metres
Latest News Resources 

West Red Lake Gold Hits 70.80 g/t Gold Over 8.3 Metres

September 12, 2023 9:10 AM Jay Lutz 0

About

Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations listed on the CSE and the TSX Venture to create quality stock analysis for investors.

Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.

Menu

  • Home
  • About
  • Research
  • Discover
  • Contact Us
  • Disclaimer

Categories

  • Automotive
  • Biotech
  • Blockchain
  • Bonds
  • Cannabis
  • Commentary
  • Education
  • Energy
  • Entertainment
  • Esports
  • ETFs
  • Food
  • Full Analysis
  • Healthcare
  • Industrials
  • Latest
  • Lithium
  • Macro
  • Market Movers
  • Mental Hurdles
  • News
  • Oil
  • Politics
  • Psychedelics
  • Real Estate
  • Resources
  • Retail
  • SPACs
  • Technology
  • Video Series
Copyright © 2023 the deep dive. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.